Ted Mikuls, MD, MSPH, Stokes-Shackleford professor of rheumatology, vice chair for research, internal medicine at the University of Nebraska, explains how lower extremity amputation among US veterans with gout was independent of body mass index (BMI) and other risk factors.
Ted Mikuls, MD, MSPH, Stokes-Shackleford professor of rheumatology, vice chair for research, internal medicine at the University of Nebraska, explains how lower extremity amputation among US veterans with gout was independent of body mass index (BMI) and other risk factors.
Transcript
Gout was associated with a 20% increase in the rate of lower extremity amputation, and patients with gout were more likely to have high BMI. Is this an important factor?
We actually included BMI as a covariate in the analysis. In other words, we accounted for differences in BMI, at least at baseline. The finding presented—the 20% increase in the rate of lower extremity amputation in gout patients—was independent of body mass index, at least at baseline. So, while BMI is a really important variable, and we know that gout patients more often suffer from obesity, the findings we're seeing appear to be independent of that. We have these patients that were matched based on age and sex. We accounted for that through that matching process, so the findings are independent of age, sex, year of the study, essentially, and then many other factors, including BMI and also including comorbidities that have been associated with amputation such as diabetes, high blood pressure, cardiovascular disease, cancers, and cigarette smoking was another factor we included in that. [The findings are] independent of all those other risk factors.
Transcript edited for clarity.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More